Suppr超能文献

内体中LLO的完整结构形式无法预防李斯特菌病。

The intact structural form of LLO in endosomes cannot protect against listeriosis.

作者信息

Rodriguez-Del Rio Estela, Frande-Cabanes Elisabet, Tobes Raquel, Pareja Eduardo, Lecea-Cuello M Jesús, Ruiz-Sáez Marta, Carrasco-Marín Eugenio, Alvarez-Dominguez Carmen

机构信息

Grupo de Genómica, Proteómica de Infecciones Bacterianas e Inflamación Fundación Marqués de Valdecilla-IFIMAV and Hospital Santa Cruz de Liencres (HUMV). Santander. Cantabria Spain.

出版信息

Int J Biochem Mol Biol. 2011;2(3):207-18. Epub 2011 Jul 15.

Abstract

LLO is the major immuno-dominant antigen in listeriosis and is also required for protective immunity. Two forms of LLO can be observed in endosomal membranes, a LLO intact form and a Ctsd-processed LLO(1-491) form. Endosomes obtained from resting macrophages contained only LLO intact forms, while endosomes obtained from IFN-activated macrophages contained both forms. Both types of endosomes elicited LLO(90-91)/CD8(+) and LLO(189-201)/CD4(+) specific immune responses. However, only endosomes containing the Ctsd-processed LLO(1-491) form showed significant CD4(+) and CD8(+) T cell responses similar to LM infected bone marrow derived macrophages and characteristic of protective Listeria immunity. Moreover, endosomes with intact LLO could not confer protection as vaccine carriers against murine listeriosis. While endosomes with Ctsd-processed LLO(1-491) form showed a moderate ability, slightly lower than high efficiency vaccine vectors as MØ infected with LM. These studies argue that all cell-free membrane vesicles might serve as valid vaccine carriers against infectious agents. Exclusively those cell-free vesicles MIIC competent for LLO processing are protective vaccines vectors since they recruit significant numbers of mature dendritic cells to the vaccination sites and contain a LLO(1-491) form that might be accessible for MHC class I and class II antigen presentation.

摘要

LLO是李斯特菌病中的主要免疫显性抗原,也是保护性免疫所必需的。在内体膜中可观察到两种形式的LLO,一种是LLO完整形式,另一种是经组织蛋白酶D处理的LLO(1 - 491)形式。从静息巨噬细胞获得的内体仅含有LLO完整形式,而从干扰素激活的巨噬细胞获得的内体则含有两种形式。这两种类型的内体均引发了LLO(90 - 91)/CD8(+)和LLO(189 - 201)/CD4(+)特异性免疫反应。然而,只有含有经组织蛋白酶D处理的LLO(1 - 491)形式的内体显示出与感染李斯特菌的骨髓来源巨噬细胞相似的显著CD4(+)和CD8(+) T细胞反应,这是李斯特菌保护性免疫的特征。此外,具有完整LLO的内体不能作为针对鼠李斯特菌病的疫苗载体提供保护。而具有经组织蛋白酶D处理的LLO(1 - 491)形式的内体显示出中等能力,略低于感染李斯特菌的巨噬细胞作为高效疫苗载体的能力。这些研究表明,所有无细胞膜囊泡都可能作为针对感染因子的有效疫苗载体。只有那些能够处理LLO的无细胞囊泡MIIC才是保护性疫苗载体,因为它们能将大量成熟树突状细胞募集到接种部位,并且含有一种可能可供MHC I类和II类抗原呈递的LLO(1 - 491)形式。

相似文献

引用本文的文献

本文引用的文献

7
Listeria monocytogenes infection in the face of innate immunity.李斯特菌感染与先天免疫。
Cell Microbiol. 2009 May;11(5):703-9. doi: 10.1111/j.1462-5822.2009.01294.x. Epub 2009 Feb 2.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验